vimarsana.com
Home
Live Updates
U.S. FDA Approves New Indication for Merck's PREVYMIS®
U.S. FDA Approves New Indication for Merck's PREVYMIS®
U.S. FDA Approves New Indication for Merck's PREVYMIS® (letermovir) for Prevention of Cytomegalovirus (CMV) Disease in High-Risk Adult Kidney Transplant Recipients
PREVYMIS now approved for CMV prophylaxis after kidney transplant in Donor CMV-seropositive/Recipient CMV-seronegative patients
... | June 6, 2023
Related Keywords
United States ,
Alaska ,
Japan ,
Canada ,
China ,
American ,
Alaskan ,
Elizabeth Rhee ,
Linkedin ,
Statement Of Merck Co Inc ,
Youtube ,
Merck Research Laboratories ,
Instagram ,
Merck Co Inc ,
Facebook ,
Drug Administration ,
Twitter ,
Aicuris Gmbh Co ,
Exchange Commission ,
Selected Safety Information ,
Merck Research ,
American Indian ,
Child Pugh Class ,
Aicuris Gmbh ,
Safety Information ,
Prescribing Information ,
Looking Statement ,
Securities Litigation Reform Act ,
Annual Report ,
Merck Co ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Revymis ,
Dow ,
Approved ,
Or ,
Dmv ,
Prophylaxis ,
After ,
Kidney ,
Transplant ,
N ,
Onor Mrk Us58933y1055 ,